Human immunodeficiency virus type 1 (HIV-1) proviral mutants that lack viral regulatory genes are unable to replicate unless rescued by complementation in trans. Structurally intact virus can be produced by infecting recombinant cell lines expressing the deficient genes. A HIV-1 mutant functionally defective in tat and rev (vIJIBATat/Rev), which replicates only in a recombinant T-cell line expressing tat and rev (CEMTWRT), is described in this report. Infection of the CEM'r"T cell line with vIIIBATt/Rv permits the complete HIV-1 life cycle, including cytopathology, decreased expression of CD4, and production of viral structural proteins, to be bioiogically contained. Culture supernatants from infected CEM'r"T contain virus that is able to replicate only in uninfected CEMTART. To create a HIV-1 provirus functionally deficient in tat and rev, physically separate mutations in the first exon of tat and both exons of rev were made. The complementary Tat and Rev gene products were both expressed from a single bicistronic mRNA derived from a spliced cDNA. These reagents therefore provided a biologically contained system to study the replication of HIV-1 in culture.
bioiogically contained. Culture supernatants from infected CEM'r"T contain virus that is able to replicate only in uninfected CEMTART. No reversion of vH[IBATat/Rev to wild-type HIV-1 was observed as mesured either by sequencing proviral vIIHBATt/Rev or by detecting the ability of vIIIBATat/Rev to replicate in CEM or activated CD4-bearlng T lymphocytes. Defective HIV-1 mutants produced by trans complementation of essential genes permit infection and analysis of defined genotypes on cellular function and phenotype. Authentic HIV-1 structural proteins and infected cells can be prepared in mass, and agents that interfere with the HIV-1 life cycle can be studied on a large scale with minimum risk ofexposing workers to virulent HIV-1.
Human immunodeficiency virus type 1 (HIV-1) proviral mutants are important to help determine the function of HIV-1 gene products. The effect of HIV-1 genes on host cell function can be examined by deletion of genes such as nef. Mutants that lack essential viral genes are unable to replicate and aspects of their function on the host cell cannot be determined. A recombinant cell line expressing essential viral regulatory genes in trans was used to complement defective molecular clones of HIV-1 to generate high-titer structurally intact virus. The defective HIV-1 generated is capable of binding and integrating in CD4-bearing T cells but of replicating only in the recombinant cells.
The initial events of the HIV-1 life cycle, including binding, fusion, entry, reverse transcription, and integration, are followed by the expression of a class of fully spliced mRNA that encodes the viral regulatory gene products Tat, Rev, and Nef (1) (2) (3) . Tat and Rev are essential trans-acting proteins, each encoded by two exons, that act to increase transcription of viral mRNA and to allow transport of unspliced mRNA to the cytoplasm, respectively. It is only following the generation of the second class of viral mRNA, which consists of unspliced and singly spliced mRNA encoding the viral proteins Gag, Pol, and Env, that virion assembly, maturation, and budding can occur (1) . The critical control of viral gene expression exerted by tat and rev made them attractive candidates for deletion to create replication-incompetent HIV-1 because each is independently required for gag, pol, and env expression.
To create a HIV-1 provirus functionally deficient in tat and rev, physically separate mutations in the first exon of tat and both exons of rev were made. The complementary Tat and Rev gene products were both expressed from a single bicistronic mRNA derived from a spliced cDNA. These reagents therefore provided a biologically contained system to study the replication of HIV-1 in culture.
MATERIALS AND METHODS
Viruses. HIV-1 was generated as described by transfection of the proviral plasmid IIIB, a derivative of HXB-3 (4). Oligonucleotide-directed mutagenesis with a bacteriophage M13 system (Amersham) was used to introduce five point mutations into the coding region of Tat and Rev in pllUBTaT/Pev.
Since Tat and Rev are encoded in different frames, mutations in the first exon of tat and rev result in a premature stop codon in tat while deleting the rev start codon. In the second exon of rev, mutations result in a premature stop codon. All mutations are shown in Table 1 .
The Tat-responsive chloramphenicol acetyltransferase (CAT) expression vector pLTR-CAT contains the HIV-1 long terminal repeat (LTR) fused to the CAT gene (4) . The Rev-responsive CAT expression vector pDM128/CMV contains the simian virus 40 (SV40) origin of replication, the cytomegalovirus (CMV) immediate-early promoter, and the bacterial CAT gene inserted into an intron regulated by Rev. pBC12/CMV/CAT contains the CMV immediate-early promoter driving expression of the CAT gene (5) washed, and, after 48 hr in culture, placed under selection with the neomycin analogue G418 (Geneticin; GIBCO), 0.3 mg/ml (active drug) for 14 days. After selection, limiting dilution cloning was performed, and genomic DNA extraction of CEM'rIT and PCR amplification were performed as described (8) (CEM'rT 5' primer, ATCGTGACCTGGGA-AGCCTTGGCTTT; CEMrART 3' primer, CTGGGGACTT-TCCACACCTGGTTGC). CAT Assay. Tat and Rev indicator elements linked to CAT were used as described (5) . COS cell cultures (60 mm) were cotransfected by calcium phosphate with 2.5 mg of either pcTAT, pcREV, pcTART, pLTARTSN, or pLXSN and 2.5 mg of either pLTR-CAT, pDM128/CMV, or pBC/CMV or with 5.0 mg of pBC12/CMV/CAT (9) . Protein extracts were prepared from cells 48 hr after transfection and levels of CAT activity were determined as described (10) . Relative protein concentrations were used to normalize CAT activity.
pJIBATat/Rev Transfection. COS cells were cotransfected by calcium phosphate with 2.5 mg of either pIHIB or pIIIBATat/Rev and 2.5 mg of either pcTAT, pcREV, pcTART, pLTARTSN, or pLXSN. Soluble p24 Gag expression was monitored using an ELISA and was quantitated in pg of p24 expression per ml by reference to standards supplied by the manufacturer (DuPont).
vIIIBATSt/Rev Infection. Following cotransfection of COS cells with 2.5 mg of either pIHIB or pHIIBATat/Rev and 2.5 mg of pLTARTSN, COS cells were maintained in culture for 72 hr and then cocultivated by the addition of 2.5 x 106 CEM or CEM'ART cells and fresh medium to maintain cells at 106 cells per ml. After an additional 72 hr, nonadherent cells were aspirated, washed, and suspended in fresh medium at 2 x 105 cells per ml at 370C in 5% CO2 containing humidified air.
Every 48 hr, cells were washed and counted, viability was determined by trypan blue dye exclusion, and cells were resuspended in fresh medium. Cells were maintained in culture for 12 weeks and 48-hr supernatants were assayed for p24 every 8 days. CEMrART for 1 hr at 370C. Infected CEMIART cells were then washed twice, counted, and resuspended in fresh medium at 2 x 105 cells per ml. Every 48 hr supernatants were aspirated and assayed for p24. Cells were washed and counted, and viability was determined by trypan blue dye exclusion. CEMTART cells were then resuspended in fresh medium at 2 X 105 cells per ml. Every 7 days, culture supernatants were used to infect fresh CEMIART or either CEM or PBLs. Culture supernatants from CEMTART infected with progeny virus were serially passed every 7 days on fresh CEMIART, and the progeny vIIIBATat/ReV produced after passage no. 4 were assayed for infectivity on CEMART, CEM, and PBLs as described.
DNA Analysis. Oligonucleotides corresponding to the 5' and 3' sequences flanking the mutations in vIIIBATat/RCv were designed to allow PCR amplification of the mutated tat and rev genes in the integrated IIIBAT"I/Rev provirus (tat and rev exon 1 mutation 5' primer, CAAACAACTGCTGTTTA-TCCA; tat and rev exon 1 mutation 3' primer, CATGGATC-CACTGCTTTGATAGAGAAACT; tat and rev exon 2 mutation 5' primer, TGGCTGTGGTATATAAAATTA; tat and rev exon 2 mutation 3' primer, CATAAGCTTGCTGAA-GAGGCACAGGCT). Following genomic DNA extraction of CEM'JrT infected with vIIIBATat/Rev and maintained in culture for 9 weeks or infected with vIIIBATat/ReV recovered after four serial passages in CEMlrT, PCR amplification and dideoxynucleotide sequencing were performed as described (11) . In addition, genomic DNA was extracted from CEM exposed to vIIIBATat/Rev and maintained in culture for 10 days. PCR amplification (Amplitaq; Cetus) and dideoxynucleotide sequencing (Sequenase; United States Biochemical) were performed as described (12) .
Inhibition with 3'-Azido-3'-deoxythymidine (AZT). Infection of CEMTART with vIIIBATat/ReV was performed in the presence of various concentrations ofAZT (13) . On day 0, 0.5 x 106 CEM or CEMTART cells were placed in six-well plates (Falcon) and incubated with AZT at final concentrations of0, 50, 5, and 0.5 mM for 1 hr in 1 ml of RPMI 1640 medium/20%o FBS at 37°C and 5% CO2 containing humidified air. One milliliter of a filtered (22-pum), 72-hr culture supernatant from COS cells cotransfected with either 2.5 pg of pIIIB or pIIIBATat/Rev and 2.5 jg ofpLTARTSN, and diluted with RPMI 1640 medium/20% FBS to contain 3 ng of p24 per ml, was added to each well. After a 1-hr incubation, 1 
in culture were aspirated, washed twice, and resuspended at 0.25 x 106 cells per ml in fresh medium containing AZT. On day 5, cells were washed twice and resuspended at 0.25 x 106 cells per ml in fresh medium containing AZT. Ninety-six-hour culture supernatants were collected at day 9 and assayed for soluble p24.
RESULTS
Construction of pIHBATat/Rev, pLTARTSN, and CEMTART.
The full genome of HIV-1 (IIIB) is depicted in Fig. 1A . The expanded view depicts the coding region between the unique Sal I and Xho I restriction sites in pIIIB. The lower, upward pointing arrows depict the locations of the missense mutations in pIIIBATat/Rev that functionally delete tat and rev.
pcTART is a cDNA expression vector that encodes both exons of tat and rev (Fig. 1B) (31) . The retroviral vector LXSN is also depicted in Fig. 1B for 14 days (CEMTART), limiting dilution cloning was performed. Genomic DNA extraction and PCR amplification using 5' and 3' oligonucleotides flanking cTART confirmed the presence of cTART in CEMTART clones (data not shown).
VIIIBATat/Rev Infection. Supernatants of COS cells transfected with pIIIB for 72 hr contained >200 pg of p24 per ml. When pIIIB was cotransfected with pcTART, pcTAT, pcREV, or pLTARTSN, similar levels (200-800 pg/ml) of p24 were produced. In contrast, supernatants of COS cells transfected with pIIIBATat/Rev for 72 hr contained no detectable p24. When pIIIBATat/Rev was cotransfected with pcTART or pLTARTSN, p24 was detected in COS cell supernatants after 72 hr at 30 pg/ml and 200 pg/ml, respectively (Fig. 2) Medical Sciences: Chen et al. (14) (15) (16) .
Currently, only transection techniques allow the introduction of defined genotypes of HIV-1 with mutations in essential genes into cells. In contrast to the inefficient methods of transfection, replication-incompetent HIV-1 would allow the efficient introduction of genetically defined HIV-1 mutants into T cells and allow the phenotypic analysis of mutations in essential genes.
Native viral proteins, complete viral particles, and virusinfected cells can all be generated in mass using the described techniques. By exploiting the constitutive expression of tat and rev in recombinant cell lines large levels of viral structural proteins are produced. Inactivated, whole killed virus preparations that may be used as vaccines against HIV-1 could be prepared with these techniques with enhanced safety over wild-type, inactivated HIV-1.
Finally, attenuated or replication-defective HIV-1 may be used in research laboratories for the safety of laboratory workers (17) (18) (19) (20) (21) . At least two cases of accidental, laboratoryacquired HIV-1 infection have been documented (21) . Biological as well as physical containment has been used to limit the risk of infection to laboratory workers (20, (22) (23) (24) (25) (26) (27) . In eukaryotic host systems, risks to laboratory workers are reduced if either no virus vector particles are produced or, if virus particles are produced, essential genes are deleted, making them replication-incompetent (28) .
Strategies to develop attenuated HIV-1 include deletion of nonessential genes such as nef, which may play a role in pathogenesis of disease (29) . This approach is based on the assumption that the pathogenesis of HIV-1 infection is related to expression of nef. Use of nef-defective mutants, though not eliminating the risk of HIV-1 infection, would theoretically reduce the risk of developing AIDS (30 
